Non-Radiology Images 

 -> https://www.jellebarentsz.com

My hobby is photography. If you like to see my flowers, landscape, birds, mammals, sea-life, insects, etc., see my non-radiology site.

Meest recente reacties

Geachte heer Laseur,
Daar weet ik te weinig van. Het beste kunt u dit met uw huisarts bespreken.
Hartelijke groet,
Jelle Barentsz

04.04 | 11:39

Nederlandse Biografie

Dutch Biography

Hier kunt u lezen, wie ik ben, wat ik heb meegemaakt en wat mijn professionele passies zijn.

Dr. Barentsz is MD since 1980 and received his research PhD in 1990. He is a Professor of Radiology since 1998 and currently the Chair of the Radboudumc Prostate MR-Reference Center.

His research led to the implementation of PI-RADS in 2012, which became the world-standard for prostate MRI. The '4M' paper from his group and other articles were the basis for the change of the European and Dutch prostate cancer guidelines. Now, it is recommended to use prostate-MRI before a biopsy.

His work also led to the "rebirth" of ferumoxtran-10 MRI, using dextran-coated iron nanoparticles as an MRI contrast agent to detect 2 mm lymph node micro-metastases. A marketing-approval trial in Germany, Switzerland and The Netherlands started in early 2020.

Dr. Barentsz' research focuses on the following aims: 

1. Implementation of PSA + prostate-MRI for early detection of prostate cancer. Use of artificial intelligence for quality control of prostate MR-image-acquisition and -interpretation.

2. Providing international virtual interactive, hands-on education to help radiologists become prostate-MRI experts. To achieve this, he is also working to implement quality control through accreditation and certification, and he is establishing an (inter)national prostate-MRI excellence network. 

3. Enable global marketing-approval of ferumoxtran-10 as MR-contrast agent, and implement nano-MRI as guidance for focal radiotherapy to treat nodal micro-metastases.

He can be stubborn, choosing to go left when everyone else goes right, if he believes it is the best path. He is determined in his decisions, but remains open to good ideas. For instance, when he proposed using MRI to detect clinically significant prostate cancer, urologists initially opposed the idea. However, he never gave up and has now been recognized with the EAU Innovators in Urology Award 2020 by European urologists. He also holds the position of Imaging Editor on the Executive Editorial Board of European Urology, where he strives to promote imaging tools that benefit patients. In his pursuit of these goals, he can sometimes become impatient, driven by his strong commitment and passion. However, he occasionally forgets that changes in medical care may take time. He is frequently sought after as a member of the Prostate Cancer Patient Society's Advisory Board, and willingly assists many patients, even outside normal working hours, providing them with (imaging) support.

In addition, he actively contributes to research in the field of prostate cancer imaging and therapy. His expertise and dedication have made him a respected figure in the medical community. He is known for his willingness to go above and beyond helping patients, even providing support outside of regular working hours.

He has authored over 350 papers, with seven published within the past two years and having a high-impact factor (> 20). His h-factor is 101, with more than 40,000 citations. Consequently, he has inspired numerous young researchers to produce exceptional articles.


Furthermore, he frequently presents his work at national and international conferences, contributing to the dissemination of knowledge in the field. He actively participates in collaborations with other institutions and clinicians, aiming to advance the effectiveness and accessibility of prostate cancer diagnosis and treatment.


Moreover, his dedication to education is evident in his role as a mentor and supervisor for medical students, residents, and fellows interested in prostate cancer imaging and therapy.

Patients and colleagues alike appreciate his approachable and compassionate nature, as he takes the time to listen attentively to their concerns, and ensure that they are well-informed and comfortable with their treatment plans. He consistently demonstrates a commitment to individualized care, tailoring approaches to the unique needs of each patient.


Overall, his expertise, passion for research, and patient-centred approach have made him a highly regarded specialist in prostate cancer imaging and therapy, shaping the standard of care in this important area of medicine.



He is very active on social media: he has more than 2000 expert-prostate followers on X and more than 1000 followers on LinkedIn.

Awards:

- Royal Decoration: Knight in the Order of the Dutch Lion

- 2020 EAU Innovators in Urology Award

- Member Academia Europaea

- Honorary Member Japanese Radiological Society (2019)

- Honorary Member Polish Medical Radiological Society (2019)

- Dutch Radiology Wertheim-Salomonson Medal

- SAR Lifetime Achievement Award

- Queen Wilhelmina Research Award (€2,000,000)

- Best Scientific Paper European Urology 2017

- 3x SCBTMR Lauterbur Award

"I have 4 dreams (that will come true):


1. Global prostate cancer early detection using PSA + MRI

2. Universal approval and use of nano-(Ferrotran)-MRI

3. Global prostate-MRI cloud-network for Artificial Intelligence.

4. Production of a nano-battery for nano-electrocution of cancer cells

Who am I?

"This (Dutch) talk for medical students shows who I am and what motivates me." 
________________________________________________________________________________________________________________

Honorary Membership Japanese Radiological Society, April 2019

Honorary Membership Japanese Radiological Society, April 2019

Honorary Membership Polish Medical Society of Radiology, June 2019

Honorary Membership Polish Medical Society of Radiology, June 2019

Best Clinical Paper European Urology 2017



Best Clinical Paper European Urology 2017

What Urologists Need to Know about MRI:

Part 1:  

https://doi.org/10.1016/j.eururo.2019.09.021…

Part 2:  

Part 3:  

Dr. Barentsz is since 2019 in the Editorial Board of European Urology as Imaging Editor. 

Combidex-MRI detects small nodal metastases, and improves treatment

This video show the experience of 2 patients with prostate cancer and Combidex MRI

PI-RADS v2.1 paper (for download below)

PI-RADS v2.1 paper (for download below)

PI-RADS v2.1

Full PI-RADS v2.1 paper by ACR PI-RADS Steering Committee

https://doi.org/10.1016/j.eururo.2018.11.023

https://doi.org/10.1016/j.eururo.2018.11.023

'4M' Study

4M Study: Prospective, multicenter, powered, comparative effectiveness study included 626 biopsy-naïve patients.

Drost et al 2019 Cochrane Review Prostate MRI

256 pages document: "A MUST for all of us who deal with Prostate Cancer!"

PI-RADS v2.1

ACR Steering Committee PI-RADS v2.1

PI-RADS v2 Update and Future Directions

PI-RADS Implementation Editorial

PI-RADS v2

Synopsis PI-RADS v2

Ferrotran nano-MRI movie

This video shows the working mechanism of Ferrotran for nano-MRI

Opmerkingen

Professional Biography (English)

Clemens M.J. Laseur

04.04.2022 10:49

Professor Jelle Barentsz.
Voor uitgezaaide blaaskanker heb ik 12 chemo behandelingen gehad.
In 'n recent radiologieverslag staat: coronaire - en mitralisklepverkalkingen. Reden voor directe actie?

Jelle Barentsz

04.04.2022 11:39

Geachte heer Laseur,
Daar weet ik te weinig van. Het beste kunt u dit met uw huisarts bespreken.
Hartelijke groet,
Jelle Barentsz

Wessel van Dijk

21.05.2021 08:09

Dag professor Barentsz. Staat u open voor nadere kennismaking. Ik zou graag eens met u spreken over Sananet prostaatkankercoach. Met Domien en Dick Janssen spreek ik al langer. Groet Wessel

Jelle Barentsz

21.05.2021 14:59

Beste Wessel,

Wat is een Sananet prostaatkankercoach?
Zullen we via e-mail verder communiceren (jelle.barentsz@radboudumc.nl)?

HG Jelle Barentsz.

04.04 | 10:49

Professor Jelle Barentsz.
Voor uitgezaaide blaaskanker heb ik 12 chemo behandelingen gehad.
In 'n recent radiologieverslag staat: coronaire - en mitralisklepverkalkingen. Reden voor directe actie?

21.05 | 14:59

Beste Wessel,

Wat is een Sananet prostaatkankercoach?
Zullen we via e-mail verder communiceren (jelle.barentsz@radboudumc.nl)?

HG Jelle Barentsz.

Dag professor Barentsz. Staat u open voor nadere kennismaking. Ik zou graag eens met u spreken over Sananet prostaatkankercoach. Met Domien en Dick Janssen spreek ik al langer. Groet Wessel

21.05 | 08:09

Deel deze pagina